Company’s 36-month beta value is -0.12.
The public float for GCTK is 24.96M, and currently, short sellers hold a 0.10% ratio of that floaft. The average trading volume of GCTK on May 08, 2025 was 5.45M shares.
GCTK) stock’s latest price update
GlucoTrack Inc (NASDAQ: GCTK)’s stock price has plunge by 6.60relation to previous closing price of 0.16. Nevertheless, the company has seen a -2.14% plunge in its stock price over the last five trading sessions. globenewswire.com reported 2025-04-16 that RUTHERFORD, N.J., April 16, 2025 (GLOBE NEWSWIRE) — Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that it will participate in the FORGETDIABETES bionic pancreas initiative that will develop a long-term, automated insulin delivery system that will enable optimal glucose control without patient intervention.
GCTK’s Market Performance
GlucoTrack Inc (GCTK) has experienced a -2.14% fall in stock performance for the past week, with a 13.91% rise in the past month, and a -76.09% drop in the past quarter. The volatility ratio for the week is 14.04%, and the volatility levels for the past 30 days are at 13.18% for GCTK. The simple moving average for the past 20 days is 2.81% for GCTK’s stock, with a -99.05% simple moving average for the past 200 days.
GCTK Trading at -30.32% from the 50-Day Moving Average
After a stumble in the market that brought GCTK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.79% of loss for the given period.
Volatility was left at 13.18%, however, over the last 30 days, the volatility rate increased by 14.04%, as shares surge +13.00% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -49.60% lower at present.
During the last 5 trading sessions, GCTK fell by -2.14%, which changed the moving average for the period of 200-days by -99.36% in comparison to the 20-day moving average, which settled at $0.1649. In addition, GlucoTrack Inc saw -97.73% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for GCTK
The total capital return value is set at -6.32. Equity return is now at value -1943.32, with -417.03 for asset returns.
Based on GlucoTrack Inc (GCTK), the company’s capital structure generated -0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -46.78.
Currently, EBITDA for the company is -21.98 million with net debt to EBITDA at 0.24. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.52.
Conclusion
In a nutshell, GlucoTrack Inc (GCTK) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
